A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.
Liquidia YUTREPIA inhalation powder gains FDA tentative approval
The Phase III INSPIRE trial served as the basis for the tentative approval. Credit: Sai Thaw Kyar/Shutterstock. Biopharmaceutical company Liquidia has received tentative approval from